Label: CURIST MUCUS RELIEF MAXIMUM STRENGTH- guaifenesin tablet, extended release

  • NDC Code(s): 72559-013-11, 72559-013-28
  • Packager: Little Pharma, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 13, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    KEEP THE CARTON. IT CONTAINS IMPORTANT INFORMATION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredient (in each extended-release tablet)

    Guaifenesin 1200 mg

  • PURPOSE

    Purpose

    Expectorant

  • INDICATIONS & USAGE

    Uses

    • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
  • WARNINGS

    Warnings

    Do not use

    • for children under 12 years of age

    Ask a doctor before use if you have

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)

    Stop use and ask a doctor if

    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DOSAGE & ADMINISTRATION

    Directions

    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for the timing of meals
    • adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
    • children under 12 years of age: do not use
  • STORAGE AND HANDLING

    Other information

    • Tamper evident: do not use if carton is open or if printed seal on blister is broken or missing.
    • store between 20°-25°C (68°-77°F)
  • INACTIVE INGREDIENT

    Inactive ingredients carbomer homopolymer type B, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

  • QUESTIONS

    Questions?

    Contact 1-844-243-1241

    or email hi@curistrelief.com

  • SPL UNCLASSIFIED SECTION

    Save 20%

    Use code MUCUSMAX20

    on your next package at

    curistrelief.com

    Limit one per customer.

    Distributed by:

    Little Pharma, Inc.

    New York, NY 10023

    Made in India

  • PRINCIPAL DISPLAY PANEL

    curist

    Mucus Relief Maximum Strength

    Guaifenesin Extended-Release Tablets 1200 mg

    Expectorant

    12 Hour

    Relieves Chest Congestion

    Thins and Loosens Mucus

    Immediate and Extended Release

    84 EXTENDED-RELEASE TABLET

    72599-013-11

  • INGREDIENTS AND APPEARANCE
    CURIST MUCUS RELIEF  MAXIMUM STRENGTH
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72559-013
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED) (UNII: K6MOM3T5YL)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeOVALSize22mm
    FlavorImprint Code G;1200
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72559-013-116 in 1 CARTON07/23/2021
    114 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:72559-013-28150 in 1 BOTTLE; Type 0: Not a Combination Product04/06/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21342007/23/2021
    Labeler - Little Pharma, Inc. (074328189)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!